Literature DB >> 19201866

The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity.

Ji Young Kim1, Keiko Ozato.   

Abstract

Sequestosome 1/p62 (p62) is a scaffold/adaptor protein with multiple functions implicated for neuronal and bone diseases. It carries a ubiquitin binding domain through which it mediates proteasome-dependent proteolysis. In addition, p62 is reported to regulate NF-kappaB activity in some cells. To date, however, the role of p62 in innate immunity has not been fully elucidated. In this study, we report that IFN-gamma plus TLR signaling stimulates late expression of p62 in murine macrophages. Overexpression of p62 inhibited expression of multiple cytokines, IL-12p40, TNF-alpha, IL-1beta, IL-6, and IFN-beta, whereas p62 underexpression by small hairpin RNA markedly elevated their expression, indicating that p62 is a broad negative regulator of cytokine expression in stimulated macrophages. We show that p62 interacts with IFN regulatory factor 8 and Ro52, the transcription factor and ubiquitin E3 ligase that are important for IL-12p40 expression. This interaction, detectable at a late stage in stimulated macrophages, led to increased polyubiquitination and destabilization of IFN regulatory factor 8. We also show that upon macrophage stimulation, p62 binds to TNFR-associated factor 6, another E3 ligase important for NF-kappaB activation, but later this interaction was replaced by the recruitment of the deubiquitinating enzyme, cylindromatosis, an inhibitor of NF-kappaB activity. Recruitment of cylindromatosis coincided with reduced TNFR-associated factor 6 autoubiquitination and lower NF-kappaB activation. Our results indicate that p62 orchestrates orderly regulation of ubiquitin modification processes in macrophages to ensure attenuation of cytokine transcription postactivation. Together, p62 may provide a mechanism by which to control excessive inflammatory responses after macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201866      PMCID: PMC4151355          DOI: 10.4049/jimmunol.0802755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation.

Authors:  Pilar Martin; Maria T Diaz-Meco; Jorge Moscat
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.

Authors:  Jeganathan Ramesh Babu; Thangiah Geetha; Marie W Wooten
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

Review 3.  Sequestosome 1/p62--more than just a scaffold.

Authors:  M Lamar Seibenhener; Thangiah Geetha; Marie W Wooten
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

4.  Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale.

Authors:  Madhuri Ramanathan; György Haskó; Samuel Joseph Leibovich
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

5.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

6.  Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts.

Authors:  Junko Aono; Toru Yanagawa; Ken Itoh; Baojie Li; Hiroshi Yoshida; Yoshito Kumagai; Masayuki Yamamoto; Tetsuro Ishii
Journal:  Biochem Biophys Res Commun       Date:  2003-05-30       Impact factor: 3.575

7.  p62 serves as a shuttling factor for TrkA interaction with the proteasome.

Authors:  Thangiah Geetha; M Lamar Seibenhener; Li Chen; Kiran Madura; Marie W Wooten
Journal:  Biochem Biophys Res Commun       Date:  2008-07-01       Impact factor: 3.575

Review 8.  Cytokine signaling modules in inflammatory responses.

Authors:  John J O'Shea; Peter J Murray
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

9.  Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Hee Jeong Kong; Akira Nishiyama; Ken J Ishii; Dennis M Klinman; Keiko Ozato
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Regulation of IFN-gamma-induced nuclear expression of IFN consensus sequence binding protein in murine peritoneal macrophages.

Authors:  A D Politis; K Ozato; J E Coligan; S N Vogel
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

View more
  47 in total

1.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

2.  Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.

Authors:  Ryusuke Yoshimi; Tsung-Hsien Chang; Hongsheng Wang; Toru Atsumi; Herbert C Morse; Keiko Ozato
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  Proteomic survey of ubiquitin-linked nuclear proteins in interferon-stimulated macrophages.

Authors:  Ji Young Kim; Eric D Anderson; Walter Huynh; Anup Dey; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2011-03-23       Impact factor: 2.607

Review 4.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

5.  TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition.

Authors:  Michael A Mandell; Ashish Jain; John Arko-Mensah; Santosh Chauhan; Tomonori Kimura; Christina Dinkins; Guido Silvestri; Jan Münch; Frank Kirchhoff; Anne Simonsen; Yongjie Wei; Beth Levine; Terje Johansen; Vojo Deretic
Journal:  Dev Cell       Date:  2014-08-07       Impact factor: 12.270

6.  p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.

Authors:  Christopher O'Connor; Thomas Pertel; Seth Gray; Seth L Robia; Joanna C Bakowska; Jeremy Luban; Edward M Campbell
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

7.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

8.  Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors.

Authors:  Rowan Higgs; Elisa Lazzari; Claire Wynne; Joan Ní Gabhann; Alexander Espinosa; Marie Wahren-Herlenius; Caroline A Jefferies
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

9.  Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent Mitophagy.

Authors:  Wan-Ting Tsai; Yin-Chiu Lo; Ming-Sian Wu; Chia-Yang Li; Yi-Ping Kuo; Yi-Hui Lai; Yu Tsai; Kai-Chieh Chen; Tsung-Hsien Chuang; Chun-Hsu Yao; Jinq-Chyi Lee; Li-Chung Hsu; John T-A Hsu; Guann-Yi Yu
Journal:  J Biol Chem       Date:  2016-07-25       Impact factor: 5.157

10.  Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide.

Authors:  Hong Bing Yu; Agnieszka Kielczewska; Annett Rozek; Shunsuke Takenaka; Yuling Li; Lisa Thorson; Robert E W Hancock; M Marta Guarna; John R North; Leonard J Foster; Oreola Donini; B Brett Finlay
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.